FibroScan Alternatives in Australia: A Buyer's Guide to Liver Elastography
What Australian buyers evaluate when comparing transient elastography systems: guidance, workflow, obese-patient performance, probes, and total cost of ownership.
FibroScan became synonymous with liver elastography, but the Australian market now includes alternatives that take different engineering approaches—particularly around ultrasound guidance and probe strategy.
This guide is written for clinical buyers and practice owners who want a structured comparison framework rather than a feature list.
Blind vs guided measurement
Blind transient elastography relies on operator skill to place the acquisition correctly without live imaging. Guided systems add B-mode visualisation so operators can see liver depth, avoid large vessels, and adapt to body habitus.
In cohorts with higher BMI, acquisition failure rates are a real-world constraint. When measurements fail, pathways slow down and patients fall back onto waiting lists.
Probe models and total cost
Some platforms require multiple probes for different patient types. Others standardise on a single probe to reduce capital complexity and staff training variance.
Australian practices should model total cost of ownership: device, warranty, training, throughput, and potential MBS-eligible workflows where clinically appropriate (always interpret with your billing advisor).
What to request in a demo
Ask to see acquisitions on a range of body habitus, the full reporting workflow, DICOM/PDF outputs, and how training is delivered for rotating staff.
If you are comparing Elastography Australia, pair the demo with the ROI calculator and your expected weekly scan volume to sanity-check payback timelines.
Next steps
Read the head-to-head comparison page for Elastography Australia vs FibroScan messaging, then book a demonstration for your clinical team.